id: topiramate_treatment_to_alcohol_craving
name: Topiramate Pharmacotherapy â†’ Alcohol Craving
from_node:
  node_id: topiramate_treatment
  node_name: Topiramate Pharmacotherapy
to_node:
  node_id: alcohol_craving
  node_name: Alcohol Craving
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Topiramate modulates glutamatergic and GABAergic neurotransmission in reward
  circuits'
- 'Step 2: Altered neurotransmitter balance reduces subjective craving for alcohol'
- 'Step 3: Reduced craving decreases motivation to consume alcohol'
- 'Step 4: Lower craving supports sustained abstinence and recovery'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Kirsten C Morley et al. 2024. "Topiramate Versus Naltrexone for
    Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled
    Trial.." *American Journal of Psychiatry*. https://doi.org/10.1176/appi.ajp.20230666'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.664802'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
